NCT07659028

Brief Summary

Numerous plant-based foods contain bioactive compounds, in particular polyphenols, which have antioxidant, anti-inflammatory, and metabolic regulatory effects. These so-called food bioactives (FB) are converted in the human organism, in particular by the gut microbiota and microsomal (liver/intestinal) metabolism, into numerous metabolites, which often represent the actual biologically active molecules. As part of the European HORIZON-MSCA Doctoral Network "BioTransform," two such food models are being studied as examples: 1. Olive products (Olea europaea L.) - representative of the Mediterranean diet, rich in secoiridoids and phenylethanols (especially hydroxytyrosol and tyrosol). 2. Bilberry /blueberry (Vaccinium myrtillus L.) - representative of the Central European diet, rich in anthocyanosides. Two parallel human intervention studies will be conducted, one in Graz (WP1, DC5) and one in Athens (WP1, DC3). These pilot studies will generate biological samples (blood, urine, stool) and investigate the extent to which taking these standardized dietary supplements influences glucose metabolism and markers of oxidative stress and low-grade inflammation.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
40mo left

Started Jul 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jul 2026Oct 2029

First Submitted

Initial submission to the registry

June 9, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 22, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2029

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2029

Last Updated

June 22, 2026

Status Verified

March 1, 2026

Enrollment Period

3 years

First QC Date

June 9, 2026

Last Update Submit

June 15, 2026

Conditions

Keywords

FOOD BIOACTIVESFOOD BIOACTIVE COMPOUNDSOLIVE PRODUCTSBILBERRY PRODUCTSOLEA EUROPEA L.BILBERRYVACCINUM MYRTILLOUS L.GUT MICROBIOMEMICROBIOME MAPPINGIN VITROIN SILICOBIOACTIVE COMPOUNDSMETABOLISM

Outcome Measures

Primary Outcomes (1)

  • Changes in inflammatory and oxidative stress markers

    The changes in the inflammatory and oxidative stress markers will be assessed through blood samples and the biomarkers: hsCRP, IL-6, TNF-a, total antioxidant capacity, ratio glutathione/ oxidiced glutathion

    14 weeks

Secondary Outcomes (5)

  • Lipid profile

    14 weeks

  • Inflammatory profile

    14 weeks

  • Anthropometric profile

    14 weeks

  • Metabolic profile

    14 weeks

  • Microbiome profile

    14 weeks

Study Arms (2)

INTERVENTION WITH OLIVE OIL EXTRACTS

EXPERIMENTAL

Group of 20 people will receive olive oil extract supplements and after the washout period will receive placebo.

Dietary Supplement: supplementation, food

INTERVENTION WITH BILBERRY

EXPERIMENTAL

Group of 20 participants will receive bilberry extract supplements and after the washout period a placebo phase.

Dietary Supplement: supplementation, food

Interventions

supplementation, foodDIETARY_SUPPLEMENT

Through this pilot clinical study, the possible change of inflammatory and oxidative stress biomarkers in prediabetic, overweigh/ obese people will be observed. Blood, urine and stool samples will be collected, while weight mangment will also be controlled.

Also known as: Body weight and composition changes, oxidative stress and inflammatory biomarkers, blood samples, urine samples, stool samples
INTERVENTION WITH BILBERRYINTERVENTION WITH OLIVE OIL EXTRACTS

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old,
  • BMI\> 25 kg/m2
  • prediabetic stage
  • hsCRP\> 2mg/ L
  • HbA1c 5,7-6,4%
  • Impaired fasting glucose (IFG)
  • Caucasian

You may not qualify if:

  • No signed informed consent
  • Supplementation or probiotic usage in the past 8 weeks
  • Chronic gastrointestinal, inflammatory or metabolic diseases
  • Alcohol misuse
  • Pregnancy or breastfeeding
  • Acute infection during the past month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laiko Hospital

Athens, 11527, Greece

Location

MeSH Terms

Conditions

Prediabetic StateObesityOverweight

Interventions

Dietary SupplementsFoodWeights and MeasuresOxidative StressBlood Specimen Collection

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet, Food, and NutritionPhysiological PhenomenaFood and BeveragesInvestigative TechniquesMetabolismStress, PhysiologicalSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

June 9, 2026

First Posted

June 22, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

July 1, 2029

Study Completion (Estimated)

October 31, 2029

Last Updated

June 22, 2026

Record last verified: 2026-03

Locations